437 related articles for article (PubMed ID: 15721415)
41. Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
Zhao Q; He Y; Wang XL; Zhang YX; Wu YM
Clin Transl Oncol; 2015 Aug; 17(8):620-31. PubMed ID: 25893434
[TBL] [Abstract][Full Text] [Related]
42. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
[TBL] [Abstract][Full Text] [Related]
43. Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells.
Chen JJ; Shen HC; Rivera Rosado LA; Zhang Y; Di X; Zhang B
Oncotarget; 2012 Aug; 3(8):833-42. PubMed ID: 22909995
[TBL] [Abstract][Full Text] [Related]
44. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand.
Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Zhang XD; Thompson JF; Screaton G; Hersey P
Hum Pathol; 2006 Oct; 37(10):1286-94. PubMed ID: 16949935
[TBL] [Abstract][Full Text] [Related]
45. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
46. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
[TBL] [Abstract][Full Text] [Related]
47. Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.
Jin Z; McDonald ER; Dicker DT; El-Deiry WS
J Biol Chem; 2004 Aug; 279(34):35829-39. PubMed ID: 15155747
[TBL] [Abstract][Full Text] [Related]
48. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.
Ramaswamy M; Efimova EV; Martinez O; Mulherkar NU; Singh SP; Prabhakar BS
Oncogene; 2004 Aug; 23(36):6083-94. PubMed ID: 15208670
[TBL] [Abstract][Full Text] [Related]
49. Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors.
Herrnring C; Reimer T; Jeschke U; Makovitzky J; Krüger K; Gerber B; Kabelitz D; Friese K
Histochem Cell Biol; 2000 Mar; 113(3):189-94. PubMed ID: 10817673
[TBL] [Abstract][Full Text] [Related]
50. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer.
Mitsiades CS; Poulaki V; Mitsiades N
J Endocrinol; 2003 Aug; 178(2):205-16. PubMed ID: 12904168
[TBL] [Abstract][Full Text] [Related]
51. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
Horak P; Pils D; Haller G; Pribill I; Roessler M; Tomek S; Horvat R; Zeillinger R; Zielinski C; Krainer M
Mol Cancer Res; 2005 Jun; 3(6):335-43. PubMed ID: 15972852
[TBL] [Abstract][Full Text] [Related]
52. Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Looi ML; Dali AZ; Ali SA; Ngah WZ; Yusof YA
Anal Quant Cytol Histol; 2008 Apr; 30(2):63-70. PubMed ID: 18561741
[TBL] [Abstract][Full Text] [Related]
53. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
Koyama S; Koike N; Adachi S
J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
[TBL] [Abstract][Full Text] [Related]
54. Podoplanin and SOX2 Expression in CIN 3-like Squamous Cell Carcinoma of the Cervix.
Stewart CJR; Crook ML
Int J Gynecol Pathol; 2018 Jan; 37(1):59-67. PubMed ID: 28319578
[TBL] [Abstract][Full Text] [Related]
55. Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor.
van der Sloot AM; Tur V; Szegezdi E; Mullally MM; Cool RH; Samali A; Serrano L; Quax WJ
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8634-9. PubMed ID: 16731632
[TBL] [Abstract][Full Text] [Related]
56. Expression of bcl-2 and bax in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Aletra C; Ravazoula P; Scopa C; Kounelis S; Sotiropoulou G; Kourounis G; Ladopoulos I; Bonikos D
Eur J Gynaecol Oncol; 2000; 21(5):494-8. PubMed ID: 11198041
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
Bonds L; Baker P; Gup C; Shroyer KR
Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
[TBL] [Abstract][Full Text] [Related]
58. FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts.
Kuang AA; Diehl GE; Zhang J; Winoto A
J Biol Chem; 2000 Aug; 275(33):25065-8. PubMed ID: 10862756
[TBL] [Abstract][Full Text] [Related]
59. Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses.
Droin NM; Pinkoski MJ; Dejardin E; Green DR
Mol Cell Biol; 2003 Nov; 23(21):7638-47. PubMed ID: 14560009
[TBL] [Abstract][Full Text] [Related]
60. Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions.
Saha B; Chaiwun B; Tsao-Wei DD; Groshen SL; Naritoku WY; Atkinson RD; Taylor CR; Imam SA
Int J Gynecol Pathol; 2007 Jul; 26(3):214-22. PubMed ID: 17581401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
